HealthAug 03, 2026
Dash Bio raises $30.0M (Aug 2026)
$30.0M
$30MGenerated social card
Headline
Exclusive: Dash Bio nets $30M for 'Amazon Web Services of drug development' - Endpoints News
About
Dash Bio is a company focused on drug development, positioning itself as the 'Amazon Web Services of drug development'. This funding round will help enhance its capabilities in the biotech sector.
Article summary
Exclusive: Dash Bio nets $30M for 'Amazon Web Services of drug development' Endpoints News
Investors
Related rounds
| Aug 14, 2026 | MiiHealth AI | $2.8M | — | United States |
| Aug 14, 2026 | Khartis | $95.0M | — | — |
| Aug 14, 2026 | InduPro | $77.0M | Series B | United States |
| Aug 13, 2026 | Wondermind | $1.2M | — | — |